Clinical Trials Browser

INDUSTRY × Ovarian Neoplasms × TQ-B3525 × Clear all

NCT04836663 2021-06-01

A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors

Phase 2 Unknown

Uterine Cervical Neoplasms, Ovarian Neoplasms